MINDBIO THERAPEUTICS CORP.

Press Releases MindBio Therapeutics Corp.

Equities

MBIO

CA60256C1086

Market Closed - Canadian Securities Exchange Other stock markets 17:00:55 27/06/2024 BST			5-day change	1st Jan Change
0.04 ^CAD	+14.29%		0.00%	+60.00%

06-20	MindBio Therapeutics Corp. Reports Durability Data from Phase 2A Clinical Trials in Depressed Patients Testing MB22001	CI
06-12	Mindbio Therapeutics Reports Secondary Data: Improvement of Psychological Outcomes & Safety Results in Depressed Patients from Phase 2A Depression Trial	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

MindBio Therapeutics Reports Secondary Data, Improvement of Psychological Outcomes and Safety Results in Depressed Patients from Phase 2A Depression Trial	06-13	AQ
MindBio Therapeutics Scientists Present Landmark Women's Health Trials, Company to Release Phase 2A Depression Trial Secondary Data This Month	05-03	AQ
MindBio Therapeutics Announces Landmark Women's Health CNS Drug Trials	05-01	AQ
MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry	04-24	AQ
MindBio Therapeutics Announces Positive Depression Data from World-First Phase 2a Take-Home Microdosing Trial	02-27	AQ
MindBio Therapeutics Completes World First Take Home Phase 2a Microdosing Depression Trial	02-15	AQ
MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research	06/09/23	AQ
MindBio Therapeutics Corp. - Begins Dosing Mb22001 in Phase 2 Clinical Trial in World First Take-Home Microdosing Study in Patients with Depression	25/08/23	AQ
Mindbio Therapeutics First Batch of MB22001 has Been Manufactured and is ready for Use in World First Phase 2 Take at Home Psychedelic Clinical Trials	21/08/23	AQ
MindBio Therapeutics Begins Recruitment of Participants for World First LSD-Microdosing Clinical Trial in Cancer Patients Experiencing Emotional Distress	26/07/23	AQ
MindBio Therapeutics World First Phase 2 Take-Home LSD-Microdosing Clinical Trial in Patients with Major Depressive Disorder Begins Pre-Screening Participants	20/07/23	AQ
MindBio Therapeutics Co-Founders Appear in Leading Australian Financial News Publication Ahead of Medicinal Psychedelics Legalisation in Australia	12/06/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer